Chevy Chase Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$86M Sell
617,014
-17,810
-3% -$2.49M 0.25% 85
2025
Q4
$77.9M Sell
634,824
-4,138
-0.6% -$503K 0.21% 100
2025
Q3
$70.9M Sell
638,962
-23,841
-4% -$2.71M 0.2% 108
2025
Q2
$73.5M Buy
662,803
+3,440
+0.5% +$366K 0.21% 100
2025
Q1
$73.9M Sell
659,363
-444
-0.1% -$45.8K 0.24% 91
2024
Q4
$60.9M Sell
659,807
-13,605
-2% -$1.22M 0.19% 109
2024
Q3
$56.5M Sell
673,412
-12,164
-2% -$928K 0.17% 116
2024
Q2
$47M Sell
685,576
-9,759
-1% -$651K 0.15% 128
2024
Q1
$50.9M Sell
695,335
-6,852
-1% -$527K 0.17% 126
2023
Q4
$56.9M Sell
702,187
-4,655
-0.7% -$362K 0.2% 105
2023
Q3
$53M Sell
706,842
-16,914
-2% -$1.3M 0.21% 102
2023
Q2
$55.8M Sell
723,756
-7,283
-1% -$581K 0.21% 104
2023
Q1
$60.7M Buy
731,039
+2,874
+0.4% +$238K 0.24% 99
2022
Q4
$62.5M Sell
728,165
-43,398
-6% -$3.44M 0.27% 95
2022
Q3
$47.6M Buy
771,563
+7,837
+1% +$494K 0.2% 106
2022
Q2
$47.2M Buy
763,726
+3,316
+0.4% +$205K 0.2% 118
2022
Q1
$45.2M Buy
760,410
+1,890
+0.2% +$121K 0.16% 133
2021
Q4
$55.1M Sell
758,520
-17,946
-2% -$1.24M 0.18% 119
2021
Q3
$54.2M Sell
776,466
-30,029
-4% -$2.11M 0.19% 119
2021
Q2
$55.5M Sell
806,495
-43,092
-5% -$2.88M 0.19% 122
2021
Q1
$54.9M Sell
849,587
-60,596
-7% -$3.91M 0.2% 121
2020
Q4
$53M Sell
910,183
-28,360
-3% -$1.71M 0.19% 122
2020
Q3
$59.3M Sell
938,543
-73,628
-7% -$5.11M 0.23% 97
2020
Q2
$77.9M Sell
1,012,171
-65,113
-6% -$4.99M 0.32% 76
2020
Q1
$80.5M Buy
1,077,284
+16,359
+2% +$1.13M 0.37% 67
2019
Q4
$68.9M Sell
1,060,925
-251
-0% -$16.3K 0.26% 92
2019
Q3
$67.3M Sell
1,061,176
-5,205
-0.5% -$340K 0.28% 85
2019
Q2
$72M Sell
1,066,381
-3,740
-0.3% -$246K 0.3% 77
2019
Q1
$69.6M Sell
1,070,121
-2,081
-0.2% -$138K 0.29% 82
2018
Q4
$67.1M Sell
1,072,202
-4,814
-0.4% -$336K 0.33% 76
2018
Q3
$83.2M Sell
1,077,016
-27,759
-3% -$2.1M 0.34% 74
2018
Q2
$78.3M Sell
1,104,775
-12,107
-1% -$855K 0.34% 74
2018
Q1
$84.2M Sell
1,116,882
-20,824
-2% -$1.66M 0.37% 64
2017
Q4
$81.5M Sell
1,137,706
-7,728
-0.7% -$587K 0.35% 68
2017
Q3
$92.8M Buy
1,145,434
+13,451
+1% +$1.03M 0.42% 53
2017
Q2
$80.1M Sell
1,131,983
-809
-0.1% -$53.8K 0.38% 59
2017
Q1
$76.9M Buy
1,132,792
+24,507
+2% +$1.72M 0.38% 58
2016
Q4
$79.4M Buy
1,108,285
+2,504
+0.2% +$186K 0.42% 56
2016
Q3
$87.5M Sell
1,105,781
-37,575
-3% -$3.05M 0.48% 47
2016
Q2
$95.4M Sell
1,143,356
-17,407
-1% -$1.54M 0.53% 44
2016
Q1
$107M Sell
1,160,763
-34,203
-3% -$3.08M 0.61% 37
2015
Q4
$121M Sell
1,194,966
-13,755
-1% -$1.43M 0.71% 30
2015
Q3
$119M Buy
1,208,721
+40,792
+3% +$4.53M 0.74% 29
2015
Q2
$137M Sell
1,167,929
-845
-0.1% -$92.3K 0.82% 23
2015
Q1
$115M Buy
1,168,774
+26,139
+2% +$2.65M 0.69% 32
2014
Q4
$108M Sell
1,142,635
-12,169
-1% -$1.26M 0.67% 30
2014
Q3
$123M Buy
1,154,804
+50,380
+5% +$4.93M 0.8% 23
2014
Q2
$91.6M Sell
1,104,424
-20,904
-2% -$1.63M 0.64% 32
2014
Q1
$79.7M Buy
1,125,328
+4,031
+0.4% +$316K 0.57% 38
2013
Q4
$84.2M Buy
1,121,297
+16,808
+2% +$1.17M 0.62% 36
2013
Q3
$69.4M Buy
1,104,489
+28,679
+3% +$1.71M 0.57% 37
2013
Q2
$55.2M Buy
+1,075,810
New +$56.1M 0.48% 39

Other funds holding GILD

Chevy Chase Trust's GILD Position: Q1 2026 in Review

Chevy Chase Trust reduced its Gilead Sciences (GILD) stake by 2.8% in Q1 2026, selling an estimated $2.49M and leaving 617,014 shares worth $86M. The position accounts for 0.25% of the portfolio, ranked #85.

Chevy Chase Trust first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $137M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Chevy Chase Trust held 617,014 shares of Gilead Sciences worth $86M as of Q1 2026.
  • Chevy Chase Trust sold 17,810 Gilead Sciences shares in Q1 2026, an estimated $2.49M.
  • Gilead Sciences made up 0.25% of Chevy Chase Trust's portfolio in Q1 2026, its #85 holding.
  • Chevy Chase Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Chevy Chase Trust's Gilead Sciences position peaked at $137M in Q2 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.